Elly Gerald Stoica

Array ( [id] => 12326100 [patent_doc_number] => 09944684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => CETP antigenic peptide and fusion protein and their composition and applications [patent_app_type] => utility [patent_app_number] => 14/920283 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 9559 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14920283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16306601 [patent_doc_number] => 10775385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers [patent_app_type] => utility [patent_app_number] => 15/736614 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 44 [patent_no_of_words] => 39266 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16666315 [patent_doc_number] => 10935553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them [patent_app_type] => utility [patent_app_number] => 15/736535 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 23758 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16144051 [patent_doc_number] => 10705094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => TNF receptor signaling modulator assay [patent_app_type] => utility [patent_app_number] => 15/736520 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 27 [patent_no_of_words] => 23257 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16666315 [patent_doc_number] => 10935553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them [patent_app_type] => utility [patent_app_number] => 15/736535 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 23758 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16666315 [patent_doc_number] => 10935553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them [patent_app_type] => utility [patent_app_number] => 15/736535 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 23758 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13302959 [patent_doc_number] => 20180203016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => MECHANISM OF ACTION [patent_app_type] => utility [patent_app_number] => 15/736336 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15802 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16666315 [patent_doc_number] => 10935553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them [patent_app_type] => utility [patent_app_number] => 15/736535 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 23758 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12842584 [patent_doc_number] => 20180172701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => ANTIBODY EPITOPE [patent_app_type] => utility [patent_app_number] => 15/736558 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24761 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11827667 [patent_doc_number] => 09724395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'Treatment of cancer with immune stimulators' [patent_app_type] => utility [patent_app_number] => 14/918675 [patent_app_country] => US [patent_app_date] => 2015-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 20560 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14918675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11942164 [patent_doc_number] => 20170246315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'THERAPEUTIC AGENTS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/519826 [patent_app_country] => US [patent_app_date] => 2015-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8607 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15519826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11942102 [patent_doc_number] => 20170246252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'Methods of Using Interleukin-10 for Treating Diseases and Disorders' [patent_app_type] => utility [patent_app_number] => 15/513825 [patent_app_country] => US [patent_app_date] => 2015-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 36552 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10685854 [patent_doc_number] => 20160031999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'IL-11R BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/886418 [patent_app_country] => US [patent_app_date] => 2015-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 48813 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14886418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10756984 [patent_doc_number] => 20160103136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'METHODS AND SYSTEMS FOR DISTINGUISHING IRRITABLE BOWEL SYNDROME FROM INFLAMMATORY BOWEL DISEASE AND CELIAC DISEASE' [patent_app_type] => utility [patent_app_number] => 14/878416 [patent_app_country] => US [patent_app_date] => 2015-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17755 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14878416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11859050 [patent_doc_number] => 09738723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Humanized anti-OX40 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/877547 [patent_app_country] => US [patent_app_date] => 2015-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 49 [patent_no_of_words] => 55503 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14877547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10750729 [patent_doc_number] => 20160096876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'COMPOSITIONS AND METHODS OF TREATING DISEASE WITH FGFR FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/877698 [patent_app_country] => US [patent_app_date] => 2015-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 58241 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14877698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11843443 [patent_doc_number] => 09730983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-15 [patent_title] => 'Methods for treatment of CD14-mediated disorders and responses' [patent_app_type] => utility [patent_app_number] => 14/873880 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 17 [patent_no_of_words] => 4680 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11528645 [patent_doc_number] => 20170088623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-30 [patent_title] => 'Prophylaxis Against Cancer Metastasis' [patent_app_type] => utility [patent_app_number] => 14/871715 [patent_app_country] => US [patent_app_date] => 2015-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8308 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14871715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656184 [patent_doc_number] => 20160002328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'Methods of Treating Kawasaki Disease using IL-1beta Antibodies' [patent_app_type] => utility [patent_app_number] => 14/861191 [patent_app_country] => US [patent_app_date] => 2015-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7835 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14861191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12023662 [patent_doc_number] => 20170313762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'BIOSENSORS FOR MONITORING BIOMOLECULE LOCALIZATION AND TRAFFICKING IN CELLS' [patent_app_type] => utility [patent_app_number] => 15/512267 [patent_app_country] => US [patent_app_date] => 2015-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 35406 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512267 [rel_patent_id] =>[rel_patent_doc_number] =>)